Entity type
Company
Filer Snapshot
Inhibrx, Inc.
CIK 0001739614. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
32
Latest filing
03 Jun 2024
Industry
Biological Products, (No Disgnostic Substances)
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: Forms 3/4/5 owner position for INBX. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
—
No parsed 13F portfolio row yet.
Browse latest 13FLargest parsed holding
—
Populates from the latest parsed 13F information table.
Open holding13D/G large stake
—
No recent parsed 13D/G stake row for this CIK.
Browse 13D/GInsider / owner context
INBX
29 May 2024
Open owner pageSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Forms 3/4/5
View source filing
4 filed on 03 Jun 2024 for CIK 0001739614.
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 11025 N. Torrey Pines Road, Suite 200, La Jolla, CA, 92037
- Incorporated in
- CA
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 2 profile fields available
Filer intelligence
What SEC filings say about Inhibrx, Inc.
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Quick read
- Forms 3/4/5 show insider context for INBX.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
Forms 3/4/5 insider context
INBX
29 May 2024 ยท 10% owner
Latest update
What changed recently for Inhibrx, Inc.
Latest ownership report period: 29 May 2024. Open the source-backed page to inspect the fresh filing or facts context.
Update date
31 May 2024
Page type
Ownership filings
Latest period
29 May 2024
Ownership context was refreshed from SEC Forms 3/4/5 filed on 31 May 2024.
Benchmark Context
Benchmark context for this company
Inhibrx, Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest ownership report period: 29 May 2024. That gives you a fresh baseline before you compare this company with peers.
- Latest company facts filing date: 09 May 2024.
- Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
- Open the facts page first if you want the cleanest path to verification.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
SEC filing record
CIK 0001739614 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
32
First seen
25 Jan 2022
Latest filing
03 Jun 2024
Entity
Company
Observed form types
10-K
10-Q
4
Industry context: Biological Products, (No Disgnostic Substances).
Latest Filings
Showing the latest 12 of 32 SEC filings for Inhibrx, Inc..
4
4 filing
- Filing date
- 03 Jun 2024
- Reporting date
- 30 May 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 30 May 2024
- Reporting date
- 30 May 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 30 May 2024
- Reporting date
- 30 May 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 30 May 2024
- Reporting date
- 30 May 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 30 May 2024
- Reporting date
- 30 May 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 30 May 2024
- Reporting date
- 30 May 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 30 May 2024
- Reporting date
- 28 May 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 30 May 2024
- Reporting date
- 30 May 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 24 May 2024
- Reporting date
- 22 May 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-Q
10-Q filing
- Filing date
- 09 May 2024
- Reporting date
- 31 Mar 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 08 May 2024
- Reporting date
- 06 May 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 28 Mar 2024
- Reporting date
- 26 Mar 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing